Hussein Rubaiy

Hussein Rubaiy is a Senior Lecturer at the Karolinska Institute, affiliated with the Department of Laboratory Medicine. His research focuses on ion channels and their roles in pharmacology, particularly in cardiovascular diseases, diabetes, and cancer therapy.

• Pharmacology (Swedish standard field)
• Toxicology (Swedish standard field)
• TRPC Channels
• ORAI Channels
• ATP-sensitive Potassium Channels

Recent publications highlight his work on TRPC1/4/5 and ORAI channels, including the development of pharmacological tools like Pico145 and Tonantzitlolone. His studies explore allosteric regulation in K_ATP channels and the therapeutic potential of targeting ion channels in disease contexts.

He contributes to clinical pharmacology through investigations into geriatric drug prescriptions and diabetes drug utilization trends in Sweden.